0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
The World in Medicine |

ALS and Neurotoxins

Joan Stephenson, PhD
JAMA. 2010;303(23):2346. doi:10.1001/jama.2010.798.
Text Size: A A A
Published online

Extract

A neurotoxin produced by cyanobacteria that has been implicated as the cause of a neurodegenerative disorder in Guam may also be produced by cyanobacteria in the Baltic Sea and elsewhere, report scientists in Sweden and the Czech Republic (Jonasson S at al. Proc Natl Acad Sci U S A. 2010;107[20]:9252-9257).

Previously, researchers proposed that a neurotoxin called β-methylamino-L-alanine (BMAA), produced by cyanobacteria in the roots of certain plants, accumulated in the food chain and caused the very high incidence of an illness similar to amyotrophic lateral sclerosis (ALS) that occurred in the Chamorro people in Guam in the late 1940s and early 1950s. Studies in animals and cultured cells, as well as studies that found BMAA in brain tissue of some patients with Alzheimer disease or ALS, also implicated BMAA as a potential factor in neurodegenerative disease.

Figures in this Article

Topics

neurotoxins

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Place holder to copy figure label and caption

Graphic Jump LocationImage not available.

A new study shows that a neurotoxin from cyanobacteria, such as from some species found in cyanobacterial blooms in the Baltic Sea, accumulates in fish and shellfish.

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
Jobs
JAMAevidence.com
brightcove.createExperiences();